Taichi Group: Shareholder Chongqing Taichi Medicinal Animal and Plant Resources Company plans to absorb and merge Xilan Biotechnology.

Taiji Group Announcement: The company's shareholder Chongqing Taiji Medicinal Plants and Animals Resources Development Co., Ltd. plans to absorb and merge with Chongqing Fuling District Xilan Biotechnology Co., Ltd. After the merger and absorption is completed, Xilan Biotechnology will be legally cancelled, and the number of shares held directly by the animal and plant resources company will change from 367,300 shares to 12,262,600 shares, accounting for 2.224% of the total share capital of the company.